Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of

Somsubhra Nath1, Abhishek Chowdhury1, Sanjib Dey1

  • 1Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

Insights

E2F1 directly regulates UbcH10 gene expression, impacting cell cycle progression. This pathway, when deregulated by Rb inactivation, leads to chromosomal instability and aneuploidy in cancer cells.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Biology

Background:

  • E2F transcription factors regulate cell cycle genes, including roles in mitosis.
  • The spindle assembly checkpoint (SAC) ensures accurate chromosome segregation.
  • Previous work identified Cdc20 as a UbcH10 regulator, but its DNA binding mechanism was unknown.

Purpose of the Study:

  • To investigate the role of E2F1 in regulating the UbcH10 gene.
  • To elucidate the mechanism of Cdc20 complex recruitment to the UBCH10 promoter.
  • To understand the consequences of E2F1-mediated UbcH10 regulation on mitotic progression and chromosomal stability.

Main Methods:

  • Chromatin immunoprecipitation assays to assess E2F1 binding to the UBCH10 promoter.
  • Reporter gene assays to measure UbcH10 promoter activity.
  • Cell cycle analysis and chromosomal abnormality scoring in response to E2F1 modulation and Rb inactivation.

Main Results:

  • E2F1-DP1 heterodimers bind to the UBCH10 promoter, mediating its transactivation.
  • Rb inactivation enhances E2F1-mediated UBCH10 transactivation.
  • E2F1-dependent UbcH10 regulation disrupts mitotic progression, causing premature anaphase, chromosomal abnormalities, and aneuploidy.

Conclusions:

  • E2F1, in complex with DP1, recruits the Cdc20-APC/C complex to the UBCH10 promoter.
  • Rb inactivation leads to excess E2F1, deregulating UbcH10 expression and promoting chromosomal instability in cancer cells.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

1.5K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K